ALL RESULTS
Showing 1-5 of 5 results

Biopharma Modalities VC Trends: Selective Bets as Investors Seek De-Risked Opportunities

Biopharma modalities' venture capital (VC) investments are becoming more selective, favoring proven assets over high-risk innovation. While cardiometabolic drugs and AI-driven drug discovery continue to attract capital, investors are shifting...
Blogs

The Rise of Private Credit: Why Investors Are Betting Big on this Asset Class

Private credit has solidified its role as a dominant investment strategy, second only to private equity (PE). In 2024 alone, global private debt fundraising reached $197.1 billion, surpassing venture capital...
Blogs

Generative AI Investors Turn to Applications

The generative AI landscape has been evolving rapidly, with foundational model companies leading the charge. However, recently investor interest is shifting away from the firms developing these foundational models to...
Blogs

China's Perfect Storm: Will Evergrande Swim or Sink?

Why investors pour money into Evergrande?  The introduction of the ‘three red lines’ rule in January 2021 by Chinese regulators set the stage for the deleveraging plan of the most indebted Chinese real estate player, Evergrande. Investors started monitoring closely the management’s efforts to deleverage the balance sheet. The group reported a drop...
Blogs

Behavioral Finance Perspective in the Investment Industry

Traditionally, all investment research and decisions are based on the assumption that individuals are risk averse, utility maximizers, and rational. Traditional finance hypothesizes that all available information is always reflected in market...
Blogs